You are here

Novo Nordisk aims to be ahead of the pharma pack with Iran investment

BT_20160125_KVNOVO25A5T4_2083244.jpg
Novo Nordisk has maintained a staff of some 130 in Iran through the sanctions era and it now plans to more than double that following a decision to invest 70 million euros on a factory in the country.

Davos

DANISH drugmaker Novo Nordisk, the world's top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran, thanks to a continuous presence and a pre-emptive investment plan.

The country is an attractive target for Big Pharma seeking to sell new

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom